Neuroprotective effects of human mesenchymal stem cells on dopaminergic neurons through anti-inflammatory action (Q46459547)

22 December 2017

title

Neuroprotective effects of human mesenchymal stem cells on dopaminergic neurons through anti-inflammatory action (English)

1 reference

22 December 2017

0 references

1 reference

1

Y Kim

1 reference

22 December 2017

Hyun-jung Park

2

Hyun-jung Park

1 reference

22 December 2017

Gwang Myeong Lee

3

Gwang Myeong Lee

1 reference

22 December 2017

Oh Young Bang

4

Oh Young Bang

1 reference

22 December 2017

Young Hwan Ahn

5

Young Hwan Ahn

1 reference

22 December 2017

E Hicks Joe

6

E Hicks Joe

1 reference

22 December 2017

Hyun Ok Kim

7

Hyun Ok Kim

1 reference

22 December 2017

Phil Hyu Lee

8

Phil Hyu Lee

1 reference

22 December 2017

publication date

1 January 2009

1 reference

22 December 2017

published in

Glia

1 reference

22 December 2017

volume

57

1 reference

22 December 2017

issue

1

1 reference

22 December 2017

page(s)

13-23

1 reference

22 December 2017

Reactive microglia are positive for HLA-DR in the substantia nigra of Parkinson's and Alzheimer's disease brains

cites work

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20731

Aspirin and salicylate protect against MPTP-induced dopamine depletion in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20731

7 January 2021

Autologous mesenchymal stem cell transplantation in stroke patients

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20731

7 January 2021

Mesenchymal stem cells: clinical applications and biological characterization.

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20731

7 January 2021

Human mesenchymal stem cells express neural genes, suggesting a neural predisposition.

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20731

7 January 2021

Immunocytochemical analysis of tumor necrosis factor and its receptors in Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20731

7 January 2021

Mesenchymal stem cells as trophic mediators

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20731

7 January 2021

Nonsteroidal anti-inflammatory drugs and the risk of Parkinson disease

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20731

7 January 2021

Pathological dynamics of activated microglia following medial forebrain bundle transection

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20731

7 January 2021

GT1b ganglioside induces death of dopaminergic neurons in rat mesencephalic cultures

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20731

7 January 2021

Neuroinflammation of the nigrostriatal pathway during progressive 6-OHDA dopamine degeneration in rats monitored by immunohistochemistry and PET imaging.

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20731

7 January 2021

Minocycline prevents nigrostriatal dopaminergic neurodegeneration in the MPTP model of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20731

7 January 2021

Distinct role for microglia in rotenone-induced degeneration of dopaminergic neurons.

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20731

7 January 2021

Mesenchymal stem cells effectively modulate pathogenic immune response in experimental autoimmune encephalomyelitis.

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20731

7 January 2021

Anti-inflammation role for mesenchymal stem cells transplantation in myocardial infarction

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20731

7 January 2021

Differential strain susceptibility following 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) administration acts in an autosomal dominant fashion: quantitative analysis in seven strains of Mus musculus.

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20731

7 January 2021

Microglia: active sensor and versatile effector cells in the normal and pathologic brain

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20731

7 January 2021

FcepsilonRII/CD23 is expressed in Parkinson's disease and induces, in vitro, production of nitric oxide and tumor necrosis factor-alpha in glial cells.

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20731

7 January 2021

Immunomodulation and neuroprotection with mesenchymal bone marrow stem cells (MSCs): a proposed treatment for multiple sclerosis and other neuroimmunological/neurodegenerative diseases

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20731

7 January 2021

Characterization of behavioral and neurodegenerative changes following partial lesions of the nigrostriatal dopamine system induced by intrastriatal 6-hydroxydopamine in the rat.

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20731

7 January 2021

Long-term rAAV-mediated gene transfer of GDNF in the rat Parkinson's model: intrastriatal but not intranigral transduction promotes functional regeneration in the lesioned nigrostriatal system.

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20731

7 January 2021

Regenerative and immunomodulatory potential of mesenchymal stem cells

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20731

7 January 2021

Evidence of active nerve cell degeneration in the substantia nigra of humans years after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine exposure

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20731

7 January 2021

Thrombin-activated microglia contribute to death of dopaminergic neurons in rat mesencephalic cultures: dual roles of mitogen-activated protein kinase signaling pathways

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20731

7 January 2021

Autologous mesenchymal stem cell therapy delays the progression of neurological deficits in patients with multiple system atrophy.

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20731

7 January 2021

Intracerebral transplantation of bone marrow stromal cells in a 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20731

7 January 2021

Inducible nitric oxide synthase stimulates dopaminergic neurodegeneration in the MPTP model of Parkinson disease

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20731

7 January 2021

Cardiomyocytes can be generated from marrow stromal cells in vitro

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20731

7 January 2021

Molecular pathophysiology of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20731

7 January 2021

Regulating factors for microglial activation

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20731

7 January 2021

Lipopolysaccharide-induced microglial activation in culture: temporal profiles of morphological change and release of cytokines and nitric oxide

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20731

7 January 2021

Immunomodulatory properties of mesenchymal stromal cells

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20731

7 January 2021

The anti-inflammatory and anti-angiogenic role of mesenchymal stem cells in corneal wound healing following chemical injury

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20731

7 January 2021

Microglial activation and dopamine terminal loss in early Parkinson's disease

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20731

7 January 2021

Multilineage potential of adult human mesenchymal stem cells

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20731

7 January 2021

Mitogen-activated protein kinases activated by lipopolysaccharide and beta-amyloid in cultured rat microglia.

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20731

7 January 2021

Thrombin induces NO release from cultured rat microglia via protein kinase C, mitogen-activated protein kinase, and NF-kappa B

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20731

7 January 2021

Cyclooxygenase-2 is instrumental in Parkinson's disease neurodegeneration

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20731

7 January 2021

Genes, proteins, and neurotoxins involved in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20731

7 January 2021

Nonsteroidal anti-inflammatory drugs may protect against Parkinson disease

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20731

7 January 2021

Unbiased stereological estimation of the total number of neurons in the subdivisions of the rat hippocampus using the optical fractionator

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20731

7 January 2021

Mesenchymal stem cells ameliorate experimental autoimmune encephalomyelitis inducing T-cell anergy.

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20731

7 January 2021

Identifiers

DOI

10.1002/GLIA.20731

1 reference

22 December 2017

PubMed ID

18661552

1 reference

22 December 2017